Graham Capital Management, L.P. Amylyx Pharmaceuticals, Inc. Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 321,867 shares of AMLX stock, worth $843,291. This represents 0.02% of its overall portfolio holdings.
Number of Shares
321,867
Previous 524,627
38.65%
Holding current value
$843,291
Previous $1.49 Million
58.97%
% of portfolio
0.02%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding AMLX
# of Institutions
140Shares Held
44.6MCall Options Held
226KPut Options Held
909K-
Vanguard Group Inc Valley Forge, PA4.22MShares$11.1 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT3.34MShares$8.75 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$6.99 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.61MShares$6.84 Million0.0% of portfolio
-
Almitas Capital LLC Santa Monica, CA1.9MShares$4.99 Million1.57% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $153M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...